Literature DB >> 26674429

Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer.

Goro Nakayama1, Chie Tanaka1, Yasuhiro Kodera1.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is the one of the most common malignancies and is a leading cause of cancer death worldwide. The incidence of mortality from CRC has decreased in Western countries because of earlier diagnosis and improved treatment modalities; however, mortality is still increasing in most other regions of the world.
SUMMARY: Progress in the development of imaging modalities has enabled more accurate staging based on the TNM classification. The therapeutic management of CRC should involve a multi-modal approach, including high-quality surgery and an optimal choice of chemotherapy and radiotherapy regimens according to disease characteristics and patient preferences. Even in the case of metastatic disease, the optimal multi-modal treatments could achieve potential cure or long-term survival benefit in some patients. The aim of this review is to present current options regarding the diagnosis, staging and treatment management for CRC based on published research reports and the current management guidelines.

Entities:  

Keywords:  Colorectal cancer; Imaging modality; Therapeutic management

Year:  2013        PMID: 26674429      PMCID: PMC4645570          DOI: 10.1159/000354995

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  19 in total

1.  Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis.

Authors:  Shandra Bipat; Afina S Glas; Frederik J M Slors; Aeilko H Zwinderman; Patrick M M Bossuyt; Jaap Stoker
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

2.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Hiroya Takiuchi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2011-10-15       Impact factor: 3.402

3.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

Review 4.  MR imaging for preoperative evaluation of primary rectal cancer: practical considerations.

Authors:  Harmeet Kaur; Haesun Choi; Y Nancy You; Gaiane M Rauch; Corey T Jensen; Ping Hou; George J Chang; John M Skibber; Randy D Ernst
Journal:  Radiographics       Date:  2012 Mar-Apr       Impact factor: 5.333

5.  Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.

Authors:  Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; David Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

Review 6.  Diagnostic accuracy of computed tomography for colon cancer staging: a systematic review.

Authors:  Anke M Leufkens; Maurice A A J van den Bosch; Maarten S van Leeuwen; Peter D Siersema
Journal:  Scand J Gastroenterol       Date:  2011-04-20       Impact factor: 2.423

7.  A comparison of laparoscopically assisted and open colectomy for colon cancer.

Authors:  Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota
Journal:  N Engl J Med       Date:  2004-05-13       Impact factor: 91.245

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

9.  Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

Authors:  Laurence E McCahill; Greg Yothers; Saima Sharif; Nicholas J Petrelli; Lily Lau Lai; Naftali Bechar; Jeffrey K Giguere; Shaker R Dakhil; Louis Fehrenbacher; Samia H Lopa; Lawrence D Wagman; Michael J O'Connell; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

10.  Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Authors:  Sabine Venderbosch; Johannes H de Wilt; Steven Teerenstra; Olaf J Loosveld; Aart van Bochove; Harm A Sinnige; Geert-Jan M Creemers; Margot E Tesselaar; Linda Mol; Cornelis J A Punt; Miriam Koopman
Journal:  Ann Surg Oncol       Date:  2011-08-06       Impact factor: 5.344

View more
  8 in total

1.  IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.

Authors:  Qingzhu Wei; Xiaoping Huang; Bo Fu; Jianghuan Liu; Ling Zhong; Qiao Yang; Tong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  Successful identification of a predictive biomarker for lymph node metastasis in colorectal cancer using a proteomic approach.

Authors:  Koichiro Mori; Yuji Toiyama; Kohei Otake; Shozo Ide; Hiroki Imaoka; Masato Okigami; Yoshinaga Okugawa; Hiroyuki Fujikawa; Susumu Saigusa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Koji Tanaka; Yasuhiro Inoue; Yuhko Kobayashi; Yasuhiko Mohri; Issei Kobayashi; Ajay Goel; Masato Kusunoki
Journal:  Oncotarget       Date:  2017-10-30

3.  Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans.

Authors:  Ailin Qu; Yongmei Yang; Xin Zhang; Wenfei Wang; Yingjie Liu; Guixi Zheng; Lutao Du; Chuanxin Wang
Journal:  EBioMedicine       Date:  2018-10-09       Impact factor: 8.143

4.  Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.

Authors:  Jian-Feng Yao; Xiao-Jun Li; Li-Kun Yan; Sai He; Jian-Bao Zheng; Xiao-Rong Wang; Pei-Hua Zhou; Li Zhang; Guang-Bing Wei; Xue-Jun Sun
Journal:  J Biochem Mol Toxicol       Date:  2019-03-21       Impact factor: 3.642

5.  Are there sex differences among colorectal cancer patients in treatment and survival? A Swiss cohort study.

Authors:  Manuela Limam; Katarina Luise Matthes; Giulia Pestoni; Eleftheria Michalopoulou; Leonhard Held; Silvia Dehler; Dimitri Korol; Sabine Rohrmann
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-04       Impact factor: 4.553

6.  Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer.

Authors:  Aling Shen; Liya Liu; Yue Huang; Zhiqing Shen; Meizhu Wu; Xiaoping Chen; Xiangyan Wu; Xiaoying Lin; Youqin Chen; Li Li; Ying Cheng; Jianfeng Chu; Thomas J Sferra; Lihui Wei; Qunchuan Zhuang; Jun Peng
Journal:  Front Cell Dev Biol       Date:  2022-01-12

Review 7.  Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic.

Authors:  Sami Akbulut; Abdirahman Sakulen Hargura; Ibrahim Umar Garzali; Ali Aloun; Cemil Colak
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

8.  In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment.

Authors:  Hassan Dana; Ghanbar Mahmoodi Chalbatani; Elahe Gharagouzloo; Seyed Rouhollah Miri; Fereidoon Memari; Reza Rasoolzadeh; Mohammad Reza Zinatizadeh; Peyman Kheirandish Zarandi; Vahid Marmari
Journal:  Drug Des Devel Ther       Date:  2020-01-23       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.